Prevalence and Contributing Factors of Isoniazid Monoresistance and Multidrug-Resistant Tuberculosis in Almaty, Kazakhstan - Top-Institutions - MDSpire

Prevalence and Contributing Factors of Isoniazid Monoresistance and Multidrug-Resistant Tuberculosis in Almaty, Kazakhstan

  • By

  • Juliana G. E. Bartels

  • Nurlan Takenov

  • Lyailya Chingissova

  • Anar Rakisheva

  • Ainur Eleusizova

  • Venera Bismilda

  • Lyazzat Yeraliyeva

  • Yanis Ben Amor

  • January 29, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Public Health

  • #2

    The London School of Hygiene & Tropical Medicine (LSHTM)
    The London School of Hygiene & Tropical Medicine (LSHTM)

    London, N/A

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Global Health

  • #3

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Clinical Research

  • #4

    The Research Institute of Phthisiopulmonology
    The Research Institute of Phthisiopulmonology

    Almaty, Kazakhstan

    Key Differentiators

    • Pulmonology
    • Infectious Diseases
    • TB Research

  • #5

    World Health Organization (WHO) Global TB Programme
    World Health Organization (WHO) Global TB Programme

    Geneva, N/A

    Key Differentiators

    • Public Health
    • Infectious Diseases
    • Epidemiology

Original Source(s)

Prevalence and Contributing Factors of Isoniazid Monoresistance and Multidrug-Resistant Tuberculosis in Almaty, Kazakhstan

  • by Juliana G. E. Bartels, Nurlan Takenov, Lyailya Chingissova, Anar Rakisheva, Ainur Eleusizova, Venera Bismilda, Lyazzat Yeraliyeva, Yanis Ben Amor

  • January 29, 2026

Related Content

Alopecia Associated with Isoniazid in Cases of Isoniazid-Monoresistant Pulmonary Tuberculosis

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Self-Management Strategies and Sputum Clearance in Pulmonary Tuberculosis: A Prospective Investigation